Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Recent studies have suggested the benefit of salvage chemotherapy (SCT) after immune checkpoint inhibitor (ICI) treatment for recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC). We retrospectively examined the outcome of SCT and the usefulness of the serum C-reactive protein...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancers (Basel)
Hoofdauteurs: Wakasaki, Takahiro, Yasumatsu, Ryuji, Masuda, Muneyuki, Takeuchi, Toranoshin, Manako, Tomomi, Matsuo, Mioko, Jiromaru, Rina, Uchi, Ryutaro, Komune, Noritaka, Noda, Teppei, Nakagawa, Takashi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2020
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7463840/
https://ncbi.nlm.nih.gov/pubmed/32824226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12082299
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items